Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Listed as NCT00023036, this observational or N/A phase trial focuses on Cytomegalovirus Infection and Sensorineural Hearing Loss and remains completed. Sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD), it has been updated 64 times since 2001, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Study Description(click to expand)Nonsyndromic hereditary hearing impairment is a genetically heterogeneous disorder that can be caused by mutations in any one of at least 60 different genes. Enlargement of the vestibular aqueduct (EVA) is a radiologic finding known to be associated with mutations in one of these genes, the Pendred syndrome gene (SLC26A4, formerly known as PDS). EVA may thus serve as a clinically useful marker to facilitate the diagnosis of hearing impairment. Recent data from our laboratory and others indicates that only a subset of individuals with EVA have SLC26A4 mutations, and therefore some EVA cases are likely to be caused by other genes, nongenetic factors, or a combination of these etiologies. Families with two or more individuals with hearing impairment and EVA will be enrolled in this study in order to identify other genetic factors that cause EVA. Siblings and parents may also be enrolled in order to define inheritance and to perform molecular genetic analyses.
Nonsyndromic hereditary hearing impairment is a genetically heterogeneous disorder that can be caused by mutations in any one of at least 60 different genes. Enlargement of the vestibular aqueduct (EVA) is a radiologic finding known to be associated with mutations in one of these genes, the Pendred syndrome gene (SLC26A4, formerly known as PDS). EVA may thus serve as a clinically useful marker to facilitate the diagnosis of hearing impairment. Recent data from our laboratory and others indicates that only a subset of individuals with EVA have SLC26A4 mutations, and therefore some EVA cases are likely to be caused by other genes, nongenetic factors, or a combination of these etiologies. Families with two or more individuals with hearing impairment and EVA will be enrolled in this study in order to identify other genetic factors that cause EVA. Siblings and parents may also be enrolled in order to define inheritance and to perform molecular genetic analyses.
Status Flow
Change History
64 versions recorded-
May 4, 2026 — Present [daily]
Completed
-
Feb 2026 — May 2026 [monthly]
Completed
-
Dec 2025 — Feb 2026 [monthly]
Completed
-
Oct 2025 — Dec 2025 [monthly]
Completed
-
Sep 2025 — Oct 2025 [monthly]
Completed
▶ Show 59 earlier versions
-
Jul 2025 — Sep 2025 [monthly]
Completed
-
May 2025 — Jul 2025 [monthly]
Completed
-
Apr 2025 — May 2025 [monthly]
Completed
-
Nov 2024 — Apr 2025 [monthly]
Completed
-
Oct 2024 — Nov 2024 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Jun 2024 — Jul 2024 [monthly]
Completed
-
May 2024 — Jun 2024 [monthly]
Completed
-
Apr 2024 — May 2024 [monthly]
Completed
-
Feb 2024 — Apr 2024 [monthly]
Completed
-
Jan 2024 — Feb 2024 [monthly]
Completed
-
Nov 2023 — Jan 2024 [monthly]
Completed
-
Oct 2023 — Nov 2023 [monthly]
Completed
-
Aug 2023 — Oct 2023 [monthly]
Completed
-
Jul 2023 — Aug 2023 [monthly]
Completed
-
Jun 2023 — Jul 2023 [monthly]
Completed
-
Apr 2023 — Jun 2023 [monthly]
Completed
-
Mar 2023 — Apr 2023 [monthly]
Completed
-
Feb 2023 — Mar 2023 [monthly]
Completed
-
Dec 2022 — Feb 2023 [monthly]
Completed
-
Sep 2022 — Dec 2022 [monthly]
Completed
-
Jul 2022 — Sep 2022 [monthly]
Completed
-
Jun 2022 — Jul 2022 [monthly]
Completed
-
May 2022 — Jun 2022 [monthly]
Completed
-
Apr 2022 — May 2022 [monthly]
Completed
-
Jan 2022 — Apr 2022 [monthly]
Completed
-
Dec 2021 — Jan 2022 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Sep 2021 — Oct 2021 [monthly]
Completed
-
May 2021 — Sep 2021 [monthly]
Completed
-
Apr 2021 — May 2021 [monthly]
Completed
-
Jan 2021 — Apr 2021 [monthly]
Completed
-
Dec 2020 — Jan 2021 [monthly]
Completed
-
Nov 2020 — Dec 2020 [monthly]
Completed
-
Oct 2020 — Nov 2020 [monthly]
Completed
-
Sep 2020 — Oct 2020 [monthly]
Completed
-
Aug 2020 — Sep 2020 [monthly]
Completed
-
Jul 2020 — Aug 2020 [monthly]
Completed
-
Jun 2020 — Jul 2020 [monthly]
Completed
-
May 2020 — Jun 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Apr 2020 — May 2020 [monthly]
Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Recruiting
-
May 2019 — Aug 2019 [monthly]
Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting
-
Dec 2018 — Apr 2019 [monthly]
Recruiting
-
Sep 2018 — Dec 2018 [monthly]
Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Sep 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
This study will try to identify and understand the genetic factors that lead to an inner ear malformation called "enlarged vestibular aqueducts", that can be associated with hearing loss. Patients with sensorineural hearing loss with or without inner ear malformations and their parents and siblings may be eligible for this study. Participants and their immediate family members, may undergo some or all of the following tests and procedures: * Medical and family history, including questions about hearing, balance and other ear-related issues, and review of medical records. * Routine physical examination. * Blood draw or buccal swab (brushing inside the cheek to collect cells) - Tissue is collected for DNA analysis to look for changes in genes that may be related to hearing loss. * Hearing tests - The subject listens for tones emitted through a small earphone. * Balance test (VEMP) to see if balance functions of the inner ear are associated with the hearing loss Electrodes will be placed behind your ear and at the base of your neck. From a reclining position, you will be asked to raise your head while clicking sounds are played into your ears. - Ultrasound tests - An inner ear malformation called EVA (enlargement of the vestibular aqueduct) indicates that a genetic disorder called Pendred syndrome may be the cause. Because thyroid abnormalities are also associated with Pendred syndrome, an ultrasound examination of the thyroid gland may be done. * Computed tomography (CT) and magnetic resonance imaging (MRI) scans - These tests show the structure of the inner ear. For CT, the subject lies still for a short time while X-ray images are obtained. For MRI, the patient lies on a stretcher that is moved into a cylindrical machine with a strong magnetic field. The magnetic field and radio waves produce images of the inner ear. The radio waves cause loud thumping noises that can be muffled by the use of earplugs.
Contact Information
- National Institute on Deafness and Other Communication Disorders (NIDCD)
For direct contact, visit the study record on ClinicalTrials.gov .